Peripheral Artery Disease News and Research

RSS
Peripheral arterial disease (PAD) occurs when leg arteries become narrowed or blocked by plaque. These blockages can result in severe pain for patients, limited physical mobility, and life-threatening non-healing leg ulcers. According to the American Heart Association, this condition affects approximately 8 to 12 million Americans. With only about 25 percent of PAD patients undergoing treatment, it is a disease that is largely under-diagnosed and under-treated. If left untreated, PAD can lead to critical leg ischemia, a condition where not enough blood is being delivered to the leg to keep the tissue alive. Total loss of circulation to the legs and feet can cause gangrene and lead to amputation.
Boston Scientific receives FDA approval for Innova Vascular Self-Expanding Stent System

Boston Scientific receives FDA approval for Innova Vascular Self-Expanding Stent System

Resverlogix announces formation of international Clinical Steering Committee for RVX-208 "apabetalone" Phase 3 trial

Resverlogix announces formation of international Clinical Steering Committee for RVX-208 "apabetalone" Phase 3 trial

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

Nebraska researchers receive $3.5 million NIH grant to study stents for peripheral artery disease

Nebraska researchers receive $3.5 million NIH grant to study stents for peripheral artery disease

Potential molecular link identified between excess fat in the blood and blood vessel recovery in ischemia

Potential molecular link identified between excess fat in the blood and blood vessel recovery in ischemia

Resverlogix and Hepalink close license agreement, sign definitive stock purchase agreement

Resverlogix and Hepalink close license agreement, sign definitive stock purchase agreement

FDA grants Fast Track designation to Juventas' JVS-100 drug candidate and allows Phase 2b clinical trial

FDA grants Fast Track designation to Juventas' JVS-100 drug candidate and allows Phase 2b clinical trial

New data on Resverlogix RVX-208 for CKD treatment presented at ERA-EDTA Congress

New data on Resverlogix RVX-208 for CKD treatment presented at ERA-EDTA Congress

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Resverlogix, Hepalink announce equity investment and license agreement for RVX-208

Resverlogix, Hepalink announce equity investment and license agreement for RVX-208

Semler receives 510(k) marketing clearance from FDA for next generation PAD testing system

Semler receives 510(k) marketing clearance from FDA for next generation PAD testing system

Valley Hospital becomes first hospital in New Jersey to use minimally-invasive approach to treat PAD

Valley Hospital becomes first hospital in New Jersey to use minimally-invasive approach to treat PAD

Duke researchers find major shift in treatments for peripheral artery disease

Duke researchers find major shift in treatments for peripheral artery disease

Resverlogix, Emerald Logic complete collaborative research program

Resverlogix, Emerald Logic complete collaborative research program

Novel technology could improve diagnosis of peripheral arterial disease

Novel technology could improve diagnosis of peripheral arterial disease

Scripps Green Hospital treats peripheral artery disease patient using new drug-coated balloon

Scripps Green Hospital treats peripheral artery disease patient using new drug-coated balloon

Jersey Coast Vascular Institute, Meridian Health partner to accept a wide range of insurances

Jersey Coast Vascular Institute, Meridian Health partner to accept a wide range of insurances

ProMedica invests in early stage medical device company

ProMedica invests in early stage medical device company

Research opens door to potential new treatments for peripheral artery disease

Research opens door to potential new treatments for peripheral artery disease

Codman Neuro Receives Approval for REVIVE SE Thrombectomy Device in China, South Korea and Taiwan

Codman Neuro Receives Approval for REVIVE SE Thrombectomy Device in China, South Korea and Taiwan